NSUP
RMD icon

NLB Skladi upravljanje premozenja’s ResMed RMD Stock Holding History

NLB Skladi upravljanje premozenja’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,312
Closed -$316K – 360
2025
Q4 		$316K Buy
+1,312
New +$336K 0.01% 307

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

NLB Skladi upravljanje premozenja's RMD Position: Q1 2026 in Review

NLB Skladi upravljanje premozenja sold out of ResMed (RMD) in Q1 2026, closing a stake of 1,312 shares — an estimated $316K sold.

NLB Skladi upravljanje premozenja first reported a position in RMD in Q4 2025 and held it in 1 quarter. The position peaked at $316K in Q4 2025. 945 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • NLB Skladi upravljanje premozenja reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • NLB Skladi upravljanje premozenja sold 1,312 ResMed shares in Q1 2026, an estimated $316K.
  • NLB Skladi upravljanje premozenja first reported a position in ResMed in Q4 2025 and held it in 1 quarter.
  • NLB Skladi upravljanje premozenja's ResMed position peaked at $316K in Q4 2025.
  • 945 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on NLB Skladi upravljanje premozenja's 13F filing for Q1 2026, filed 11 May 2026.